Skip to main content
Caplight Logo









mAbsolve Ltd.

mAbsolve Ltd.

Private
OxfordHealthcare & Life Scienceshttps://mabsolve.com/

Last Round

Seed

Mar 3, 2020

Total Funding Raised

$179,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

mAbsolve Ltd. is a biotechnology company that develops and licenses its proprietary STR Fc silencing technology to improve the safety and effectiveness of therapeutic antibodies and Fc fusion proteins.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

Fc silencingtherapeutic antibodiesantibody engineeringFc fusion proteinsbiotech licensingantibody drug developmentprotein engineeringbiopharmaceutical technologyCDMOcontract development and manufacturing organizationantibody platformdrug discoverymolecular engineeringbiotech IP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

mAbsolve Ltd. Comparables

Compare mAbsolve Ltd. with similar companies based on industry and business-model similarity.

mAbsolve Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CROSSPOINT Therapeutics
86%
AbFinder Therapeutics Co., Ltd.
65%
Vector Laboratories
64%

mAbsolve Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 3, 2020

Key People

Founding team and executive leadership

Ian Wilkinson

Co-Founder and Chief Scientific Officer

Founding Team

Geoff Hale

Chief Executive Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors grew 162% MoM, reaching 2.5K.

  • Nov 9, 2025

    Monthly visitors increased 122% MoM.

mAbsolve Ltd. Filings

Explore SEC and related filing metadata, where available.

mAbsolve Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about mAbsolve Ltd.'s valuation, stock price, and market status.

Is mAbsolve Ltd. a public or private company?

mAbsolve Ltd. is a private company.

What is the current stock price of mAbsolve Ltd.?

mAbsolve Ltd. is a private company with no public stock price. Caplight tracks mAbsolve Ltd.'s secondary market activity and provides MarketPrice estimates to Caplight users.

How much is mAbsolve Ltd. worth (valuation)?

Valuation information for mAbsolve Ltd. is not publicly available.

Can I buy mAbsolve Ltd. stock?

mAbsolve Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was mAbsolve Ltd.'s last funding round?

mAbsolve Ltd.'s most recent funding round was Seed on March 3, 2020.

Who are the main investors in mAbsolve Ltd.?

Investor information for mAbsolve Ltd. is not publicly disclosed.

Will mAbsolve Ltd. IPO soon?

No public IPO plans have been announced for mAbsolve Ltd..

How can I track mAbsolve Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor mAbsolve Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOxford
Employee Range6
Year Founded2019
Last FundingMar 3, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?